World's Best Scientists 2026 revealed!
Gordon W. Dewald

Gordon W. Dewald

D-Index & Metrics

Genetics

D-Index
88
Citations
28234
World Ranking
1172
National Ranking
564

Medicine

D-Index
92
Citations
31600
World Ranking
11293
National Ranking
5795

Overview

Gordon W. Dewald was a researcher affiliated with the Mayo Clinic in the United States. Their work focused primarily on various fields of medicine, with notable contributions in hematology, public health, environmental and occupational health, and pediatrics, perinatology, and child health.

Their research addressed key topics including:

  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Childhood Cancer Survivors' Quality of Life

Dewald's recent scholarly output included publications spanning hematologic disorders and leukemia risk assessment. Notable papers included:

  • "Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL", published in 2021 in Blood
  • "Guidance for Fluorescence in Situ Hybridization Testing in Hematologic Disorders", published in 2020 in UNC Libraries

Throughout their career, Dewald collaborated frequently with other researchers. Their common coauthors were:

  • Elisabeth Paietta
  • Kathryn G. Roberts
  • Victoria Wang
  • Zhaohui Gu
  • Georgina Buck

Their publications appeared predominantly in the venues Blood and UNC Libraries, with at least one contribution to each.

Best Publications

  • Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

    Alan List;Gordon Dewald;John Bennett;Aristotle Giagounidis

  • Anthracycline Dose Intensification in Acute Myeloid Leukemia

    Hugo F. Fernandez;Zhuoxin Sun;Xiaopan Yao;Mark R. Litzow

  • Establishment of an immature mast cell line from a patient with mast cell leukemia.

    J. H. Butterfield;D. Weiler;G. Dewald;Gerald J. Gleich

  • Clinical and biologic implications of recurrent genomic aberrations in myeloma

    Rafael Fonseca;Emily Blood;Montserrat Rue;David Harrington

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

    Anthony V. Moorman;Christine J. Harrison;Georgina A.N. Buck;Sue M. Richards

  • The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes.

    David P. Steensma;David P. Steensma;Gordon W. Dewald;Gordon W. Dewald;Terra L. Lasho;Terra L. Lasho;Heather L. Powell;Heather L. Powell

  • Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1–risk myelodysplastic syndromes with karyotypes other than deletion 5q

    Azra Raza;James A. Reeves;Eric J. Feldman;Gordon W. Dewald

  • The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis

    Gordon W. Dewald;Robert A. Kyle;Gary A. Hicks;Philip R. Greipp

  • Phase III Trial of Fludarabine Plus Cyclophosphamide Compared With Fludarabine for Patients With Previously Untreated Chronic Lymphocytic Leukemia: US Intergroup Trial E2997

    Ian W. Flinn;Donna S. Neuberg;Michael R. Grever;Gordon W. Dewald

  • Genomic abnormalities in monoclonal gammopathy of undetermined significance

    Rafael Fonseca;Richard J. Bailey;Gregory J. Ahmann;S. Vincent Rajkumar

  • Comprehensive Assessment of Genetic and Molecular Features Predicting Outcome in Patients With Chronic Lymphocytic Leukemia: Results From the US Intergroup Phase III Trial E2997

    Michael R. Grever;David M. Lucas;Gordon W. Dewald;Donna S. Neuberg

  • CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

    Animesh Pardanani;Animesh Pardanani;Animesh Pardanani;Rhett P. Ketterling;Rhett P. Ketterling;Rhett P. Ketterling;Stephanie R. Brockman;Stephanie R. Brockman;Stephanie R. Brockman;Heather C. Flynn;Heather C. Flynn;Heather C. Flynn

  • T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).

    David I. Marks;Elisabeth M. Paietta;Anthony V. Moorman;Susan M. Richards

  • Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.

    Yaping Shou;Maria L. Martelli;Ana Gabrea;Ying Qi

  • Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia

    Neil E. Kay;Susan M. Geyer;Timothy G. Call;Tait D. Shanafelt

  • The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

    Rafael Fonseca;Carina S. Debes-Marun;Elisa B. Picken;Gordon W. Dewald

  • FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia.

    Animesh Pardanani;Stephanie R. Brockman;Sarah F. Paternoster;Heather C. Flynn

  • Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

    Rafael Fonseca;Emily A. Blood;Emily A. Blood;Martin M. Oken;Martin M. Oken;Robert A. Kyle;Robert A. Kyle

  • A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group

    Jacob M. Rowe;Donna Neuberg;William Friedenberg;John M. Bennett

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia

    A Moorman;C J Harrison;Buck Gan.;S M Richards

Frequent Co-Authors

Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Neil E. Kay
Neil E. Kay Mayo Clinic
Jacob M. Rowe
Jacob M. Rowe Technion – Israel Institute of Technology
Mark R. Litzow
Mark R. Litzow Mayo Clinic
Curtis A. Hanson
Curtis A. Hanson Mayo Clinic
John M. Bennett
John M. Bennett University of Rochester Medical Center
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Tait D. Shanafelt
Tait D. Shanafelt Stanford University
Donna Neuberg
Donna Neuberg Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Genetics opens doors to a variety of rewarding careers in healthcare and the sciences. For many students, online programs can be an accessible pathway to advanced roles. There are several related fields to consider if you want flexibility or a broader perspective.

Those interested in nursing may benefit from nursing schools that do not require entrance exam requirements, making it easier to begin a healthcare career. For further progression, professionals can find the cheapest online nursing phd programs to boost credentials without a large financial burden.

If quick entry into the workforce is your goal, there are fast track medical programs available online that shorten the timeline to becoming a Licensed Practical Nurse (LPN). For those aiming for healthcare administration roles, you can also review the most affordable mha programs that prepare graduates for leadership positions in the medical field.

Each of these pathways complements a background in Genetics and can enhance your career opportunities in the expanding landscape of health sciences.

Best Scientists Citing Gordon W. Dewald

Recently Published Articles